Lowering Costs ... Seth will focus on creating good jobs and lowering costs by: Lowering the cost of prescription drugs by allowing Medicare to negotiate with pharmaceutical companies.
Seth will focus on creating good jobs and lowering costs, including lowering the cost of prescription drugs by allowing Medicare to negotiate with pharmaceutical companies.
Occurrences
Fight to lower the cost of prescription drugs by allowing Medicare to negotiate prices so all Americans are able to afford life-saving medications
Representative Magaziner is committed to ensuring high-quality, affordable health care, including mental health care, for every American. In Congress, Rep. Magaziner is fighting to lower healthcare costs, and especially to lower the cost of prescription drugs like insulin for all Americans.
He has introduced bills to lower drug prices
Evidence
unverified · Source version 12024 · locator unknown
Magaziner’s campaign issue page says that in Congress he will "fight to lower the cost of prescription drugs by allowing Medicare to negotiate prices" and support expanding those lower negotiated prices to people with private insurance.
unverified · Source version 83300 · locator unknown
The enacted law creates a Medicare Drug Price Negotiation Program and states that the Secretary of HHS shall negotiate maximum fair prices for selected drugs, with the first price applicability year beginning in 2026.
unverified · Source version 70738 · locator unknown
The bill was introduced by Rep. Magaziner and would amend the Medicare drug price negotiation program and related out-of-pocket timing rules to lower prescription drug costs.
unverified · Source version 83300 · locator unknown
The law creates a Drug Price Negotiation Program and requires the Secretary to negotiate maximum fair prices for selected drugs.
unverified · Source version 70738 · locator unknown
Magaziner introduced H.R.5924 to adjust the timing of Medicare drug-price negotiation and the out-of-pocket threshold; the bill remains in introduced status and was later referred to subcommittee.
unverified · Source version 83296 · locator unknown
"The negotiations with participating drug companies will occur in 2026, and any negotiated prices will become effective beginning in 2028."
unverified · Source version 59196 · locator unknown
"Comments must be received by September 18, 2026."
unverified · Source version 59198 · locator unknown
"The Plaintiffs challenge the constitutionality of the Drug Pricing Program created by the Inflation Reduction Act of 2022." "The district court’s grant of summary judgment to the Government is AFFIRMED."
unverified · Source version 59192 · locator unknown
"Representatives Seth Magaziner (RI-02) and Gabe Amo (RI-01) announced $4,619,389 of federal funding awarded by the National Science Foundation (NSF) to the University of Rhode Island"
unverified · Source version 59200 · locator unknown
"The Secretary shall establish a Drug Price Negotiation Program" "negotiate and, if applicable, renegotiate maximum fair prices for such selected drugs"
unverified · Source version 59202 · locator unknown
"Status: Introduced on October 11 2023 - 25% progression, died in committee"
unverified · Source version 83299 · locator unknown
"On January 1, 2026, new negotiated maximum fair prices under the Medicare Drug Price Negotiation Program went into effect"
unverified · Source version 70738 · locator unknown
"Sponsor: Rep. Magaziner, Seth [D-RI-2] (Introduced 10/11/2023)"
unverified · Source version 83296 · locator unknown
"Selected Drug List and Negotiated Prices, also known as Maximum Fair Prices in Statute (ZIP) (September 21, 2026)" "The negotiations with participating drug companies will occur in 2026, and any negotiated prices will become effective beginning in 2028."
unverified · Source version 83298 · locator unknown
"The comment period closed on September 18, 2026 and CMS anticipates issuing the final guidance later this year."
unverified · Source version 83300 · locator unknown
"The Secretary shall establish a Drug Price Negotiation Program" "negotiate and, if applicable, renegotiate maximum fair prices"
unverified · Source version 83302 · locator unknown
"Mr. MAGAZINER introduced the following bill" "to amend title XI of such Act with respect to the timing of the Medicare drug price negotiation program."
unverified · Source version 83304 · locator unknown
"This final rule implements the Global Benchmark for Efficient Drug Pricing Model (GLOBE Model), a new mandatory Medicare payment model" "reduces costs for Original Medicare (OM) beneficiaries and the Medicare program"
Assessments
Medicare drug-price negotiation was enacted in the Inflation Reduction Act before Magaziner took office, so the core policy outcome exists, but it was not achieved through his own term or chiefly his own action. He did run on the issue and later introduced related legislation to refine the negotiation program, which warrants partial credit rather than full delivery.
The core promised policy was to lower prescription drug costs by allowing Medicare to negotiate prices with pharmaceutical companies. That authority was enacted in the Inflation Reduction Act of 2022, creating the Medicare Drug Price Negotiation Program, with negotiated prices scheduled to take effect beginning in 2026. Magaziner also took concrete same-term legislative action by introducing H.R.5924 to further strengthen or adjust the program. Because the central policy outcome exists, the promise is best rated delivered, though the timing is marked unknown because the enabling law passed before Magaziner began serving in Congress rather than clearly during his own term.